2017 Symposium on Rotavirus Human Immunology Held
On May 15-16, 2017, the University of Vermont’s Vaccine Testing Center hosted fifteen of the world’s leading Rotavirus researchers at their Symposium on Rotavirus Human Immunology: Advancing Science, Decreasing Disease. These scientists joined investigators from the Vaccine Testing Center to tackle major outstanding scientific issues needed for the control of disease burden from Rotavirus diarrhea, the leading cause of child death due to severe diarrhea. Scientists representing The Bill & Melinda Gates Foundation, the non-governmental organization PATH, and the U.S. Centers for Disease Control and Prevention were in attendance. In addition, eleven U.S. and international academic institutions were represented, including those from Columbia (Pontificia Universidad Javeriana, Dr. Manuel Franco Cortes), India (Christian Medical College, Dr. Gagandeep Kang), and Bangladesh (icddr,b; Dr. Rashidul Haque). Full article.
Dr. Kristen Pierce Receives UVM Early Achievement Award
Kristen Pierce, MD ’02, has been awarded the prestigious Early Achievement Award by the Larner College of Medicine’s Office of Development and Alumni Relations. This award is presented to an alumnus of UVM who has graduated within the past 15 years in recognition of their outstanding community or College service, scientific, or academic achievement. Dr. Pierce, an Associate Professor who specializes in Infectious Diseases, is a Principal Investigator at the Vaccine Testing Center where she has led trials and research on dengue, zika and other globally infectious diseases. We’d like to congratulate Dr. Pierce on this achievement!
Partners in Dhaka Fight Diarrheal Diseases...and Win!
The Vaccine Testing Center has collaborated with the International Center for Diarrheal Disease and Research (icddr, b) in Dhaka, Bangladesh, since 2002. This partnership has yielded valuable information and deep relationships between the two centers. Our colleagues were recently featured in a New York Times article entitled Turning the Tide Against Cholera, which highlights the low-tech, highly effective treatment for diarrhea that was developed by icddr, b and which the World Health Organization estimates has saved 50 million lives worldwide in the past four decades.
Beth Kirkpatrick, MD, Director of the Vaccine Testing Center Inducted into ASCI
Beth Kirkpatrick, M.D., professor in the Division of Infectious Disease and Director of the UVM Vaccine Testing Center, was recently inducted into the American Society for Clinical Investigation (ASCI), one of the oldest and most well-respected medical honor societies in the nation. Made up of more than 3,000 physician-scientists, ASCI elects members "for their outstanding records of scholarly achievement in biomedical research." The council elects just 80 new members every year out of the hundreds of nominations received.
E. Ross Colgate Featured on UVM's "Meet a Scientist" Series
Vaccine Testing Center Researcher and Analyst E. Ross Colgate, MPH, was recently featured as part of UVM Graduate Education's "Meet a Scientist" series, as well as the Larner College of Medicine's LarnerMed Instagram page. Colgate's research into rotavirus vaccine underperformance in Bangladesh is an important step toward understanding why a vaccine that has proven effective in the U.S. is far less effective at disease prevention in certain other populations. View Ross' Instagram post and learn more by reading the Meet a Scientist article.
VTC Faculty Member Kelly Cowan, MD, Receives Grant to Study Environmental Influences on Child Health
Vaccine Testing Center faculty member Kelly Cowan, M.D., a pediatric pulmonologist at the University of Vermont Children’s Hospital and assistant professor of pediatrics at The Robert Larner, M.D. College of Medicine at The University of Vermont, received a $1.84 million four-year grant as part of the National Institutes of Health’s Environmental influences on Child Health Outcomes (ECHO). The ECHO program aims to discover how early childhood exposure to certain environmental factors might influence the health of children and adolescents. The Vermont program is called IMproving Pediatric Access to Clinical Trials in Vermont – or IMPACT VT. Learn more about the ECHO program and Dr. Cowan’s research.
Pierce and Diehl Present at Community Medical School UVM
Vaccine Testing Center researchers Kristen Pierce, M.D., associate professor of medicine, and Sean Diehl, Ph.D., assistant professor of medicine, were recently invited to present at UVM's Larner College of Medicine's Community Medical School lecture series. In a November 1 presentation entitled, "The Dengue Fever Vaccine: How It Can Help Us Defend Against Zika Virus", Drs. Pierce and Diehl discussed their important roles in the development of an effective Dengue vaccine and how that experience has helped in the development of a vaccine against Zika virus. You can view the handout and video at the Community Medical School page.
Article features VTC Researcher/Analyst
Mary Claire Walsh, P.A., Study Clinician, Researcher, and Analyst at the VTC, was recently featured in The Exeter Bulletin's Nex-Gen Medicine article "Meet Five Alumni Whose Science is Saving Lives". The piece features Philips Exeter Academy alumni who are among the current pioneers on the medical frontier and whose passion for their work and commitment to patients goes above and beyond. Read the article..
Vaxchora: Groundbreaking Cholera Approval
The U.S. Food and Drug Administration recently approved Vaxchora, the first adult cholera vaccine available in the United States. Testing for the vaccine was conducted by researchers at the UVM Vaccine Testing Center with the help of local volunteers. Read the FDA Press Release, check out the WCAX news story or catch up with the feature article on the Larner College of Medicine website.
VTC Helps Develop First Effective Single Dose Dengue Vaccine
UVM Vaccine Testing Center recently had an article published in Science Translational Medicine on the results of a groundbreaking clinical trial conducted by the VTC, the National Institutes for Health, and John Hopkins University that revealed an effective, single-dose dengue vaccine. Read more here or see the story in Science Translational Journal.
Developing a vaccine for Zika
Vaccine Testing Center researchers talk to news reporters about the ongoing Zika outbreak and the work that will be done here at VTC to help develop a vaccine for Zika.
Rotavirus Interview on VPR
Researcher/Analyst Ross Colgate of the UVM Vaccine Testing Center was recently interviewed on VPR Vermont Edition regarding the VTC's recent Rotavirus immunology award. Listen to the full interview here.
Publications and Awards
E. Ross Colgate was Awarded the "Trainee Award for Outstanding Research Publication" at the inaugural Dean's Excellence in Research Awards at the Robert Larner, M.D., College of Medicine at the University of Vermont. Learn more about the award..
Dr. Benjamin Lee receives Hood Foundation & Thrasher Awards Read the full article to learn more about the awards and Dr. Lee's research.
Bill and Melinda Gates Foundation Award for Rotavirus Immunology Study For the full article, click here. .
Drs. Kirkpatrick and Pierce publish new Dengue research..
Dr. Kirkpatrick, et al. publish new Rotavirus and Oral Polio Vaccine research..
Bill and Melinda Gates Foundation Award for Dengue Immunology Study For the full article, click here. .
Drs. Jon Boyson and Jason Botten join the Vaccine Testing Center on Dengue Immunology Grant with the Gates Foundation.